<page><tag>3</tag><title>Drug: Test results excite Alpharetta maker</title><text>Alpharetta-based AtheroGenics announced positive interim results Monday from a clinical trial of its drug to treat atherosclerosis, which leads to coronary heart disease.</text></page>